Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AFN-12520000 in Staphylococcal ABSSSI
NCT01519492Phase 2Completed
- Sponsor
- Affinium Pharmaceuticals
- Start
- Feb 2012
- Primary completion
- Aug 2012
- Countries
- 2
01
Overview
A Phase 2 trial of afabicin desphosphono in acute bacterial skin and skin structure infection (ABSSSI), sponsored by Affinium Pharmaceuticals. Started Feb 2012; status: completed.
02
Drugs
afabicin desphosphono
03
Conditions
acute bacterial skin and skin structure infection (ABSSSI)
Beyond the preview
Go deeper on NCT01519492.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01519492.